Human deficiencies of pigment formation, including oculocutaneous albinism are common genetic abnormalities with severe cutaneous and optic system effects. A reduction of melanin production in the skin results in a marked sensitivity to ultraviolet radiation and a predisposition of skin cancer. Reduction of melanin in the eye during development is associated with life- long nystagmus, foveal hypoplasia with reduced visual acuity, and abnormal routing of the neural connections from the retina to the brain, resulting in strabismus and loss of binocular vision. The clinical characteristics of six or more types of human oculocutaneous albinism have been described, and it is now clear that some of these result from different mutations at a single locus (allele heterogeneity), while others result from mutations at different loci (locus heterogeneity). The overall aims of this project are to investigate the clinical, ophthalmological, hematological, epidemiological, biochemical and molecular features of normal and abnormal human pigment formation, particularly oculocutaneous albinism. These studies will provide information which we hope will lead to methods of accurate diagnosis, therapy, and family counseling, so that these genetic diseases can be prevented, treated, or ameliorated. Four projects and a core facility will be utilized for this work. Project 1 will analyze the molecular and the biochemical characteristics of the different types of tyrosinase-related oculocutaneous albinism. Project 2 will analyze the defects in regulatory mechanisms and membranes in platelets and blood cells in patients with hypopigmentation, including the Hermansky-Pudlak syndrome. Project 3 will analyze the human correlate of the mouse pink-eyed dilution gene and will look for a type of human oculocutaneous hypopigmentation that is associated with changes in this gene. Project 4 will analyze the biology of the melanocyte int he different types of human oculocutaneous albinism. The core facility will provide support for the ophthalmologic evaluation of the patients seen in the different projects, for the biophysical analysis of the structure and function of the melanin isolated in the different projects, and for the development of a transgenic mouse model of pigmentation that can be used in the analysis of the effects of melanin on the development of the optic and auditory system.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM022167-19
Application #
2173881
Study Section
Special Emphasis Panel (SSS (K))
Project Start
1986-12-01
Project End
1996-12-30
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
19
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Oetting, W S; King, R A (1999) Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat 13:99-115
Orlow, S J; Brilliant, M H (1999) The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye. Exp Eye Res 68:147-54
Oetting, W S; Armstrong, C M; Ronan, S M et al. (1998) Multiplexed short tandem repeat polymorphisms of the Weber 8A set of markers using tailed primers and infrared fluorescence detection. Electrophoresis 19:3079-83
Sweet, H O; Brilliant, M H; Cook, S A et al. (1998) A new allelic series for the underwhite gene on mouse chromosome 15. J Hered 89:546-51
Wildenberg, S C; Fryer, J P; Gardner, J M et al. (1998) Identification of a novel transcript produced by the gene responsible for the Hermansky-Pudlak syndrome in Puerto Rico. J Invest Dermatol 110:777-81
Oetting, W S; Gardner, J M; Fryer, J P et al. (1998) Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online. Hum Mutat 12:434
Oetting, W S; Fryer, J P; King, R A (1998) Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online. Hum Mutat 12:433-4
Lehman, A L; Nakatsu, Y; Ching, A et al. (1998) A very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice. Proc Natl Acad Sci U S A 95:9436-41
Gardner, J M; Wildenberg, S C; Keiper, N M et al. (1997) The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome. Proc Natl Acad Sci U S A 94:9238-43
Puri, N; Durbam-Pierre, D; Aquaron, R et al. (1997) Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene. Hum Genet 100:651-6

Showing the most recent 10 out of 125 publications